Biogen, Eisai sign strategic manufacturing deal at Research Triangle Park
According to the lease agreement signed for ten years, Biogen will use a part of the Eisai facility to produce oral solid dose products for both the firms
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
TeraMedica’s patented Smartstore module intelligently manages the total image lifecycle of all DICOM and non-DICOM content, while the Univision module provides a multi-layer, zero-download image viewer, with seamless
IPR is involved in upgrading and manufacturing control and automation products, inspection systems for pharmaceutical equipment such as tablet presses. Bosch Packaging Services general manager Gary Anderton said